KARLA HORTON: Open Payments
NPI 1710934823 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,772 in 187 payments from 23 companies in 2025. Trend: 2023 $11,320 · 2024 $7,824 · 2025 $6,772
Consulting: $3,390Food & beverage: $3,287Education: $96
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $2,326 |
| Novartis Pharmaceuticals Corporation | 10 | $1,548 |
| ABBVIE INC. | 26 | $478 |
| Janssen Biotech, Inc. | 24 | $371 |
| LEO Pharma Inc. | 19 | $347 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $189 |
| E.R. Squibb & Sons, L.L.C. | 9 | $183 |
| Amgen Inc. | 8 | $181 |
| PFIZER INC. | 8 | $179 |
| Regeneron Healthcare Solutions, Inc. | 5 | $166 |
Products named: Bimzelx, SKYRIZI, TREMFYA, ADBRY, DUPIXENT, Sotyktu, OTEZLA, CIBINQO.
Industry payments across AZ — which companies pay providers there.
